| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/02/2023 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 5.7k | $74.12 | $421.1k | | 06/02/2023 |
| 03/02/2023 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 2.1k | $65.32 | $136k | | 03/02/2023 |
| 01/11/2023 | Liquidia Corp | | Grant | Common Stock | 289.5k | $0.00 | $0 | | 01/11/2023 |
| 01/11/2023 | Liquidia Corp | | Grant | Stock Option (Right to Buy) | 371.2k | $6.17 | $2.3M | | 01/11/2023 |
| 01/03/2023 | Liquidia Corp | | Exercise | Restricted Stock Unit | 15.8k | $0.00 | $0 | | 01/03/2023 |
| 10/03/2022 | Liquidia Corp | | Exercise | Restricted Stock Unit | 47.4k | $0.00 | $0 | | 04/03/2022 |
| 09/06/2022 | Liquidia Corp | | Purchase | Common Stock | 43.8k | $5.57 | $244k | | 09/06/2022 |
| 08/31/2022 | Liquidia Corp | | Purchase | Common Stock | 993 | $4.90 | $4.9k | | 08/31/2022 |
| 06/17/2022 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 931.5k | $4.86 | $4.5M | | 06/17/2022 |
| 06/03/2022 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 17k | $25.53 | $433.4k | | 06/03/2022 |
| 05/24/2022 | Liquidia Corp | | Purchase | Common Stock | 28k | $3.53 | $98.8k | See footnote | 05/24/2022 |
| 03/31/2022 | Liquidia Corp | | Grant | Common Stock | 154.2k | $0.00 | $0 | See footnote | 03/31/2022 |
| 03/04/2022 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 2.3k | $29.91 | $70.2k | | 03/04/2022 |
| 01/03/2022 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 1.7M | $5.14 | $8.6M | | 01/03/2022 |
| 01/03/2022 | Liquidia Corp | | Grant | Restricted Stock Unit | 63.2k | $0.00 | $0 | | 01/03/2022 |
| 11/19/2021 | Axsome Therapeutics, Inc. | AXSM | Purchase | Common Stock | 4k | $37.30 | $147.4k | | 11/19/2021 |
| 08/20/2021 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 20k | $2.59 | $51.8k | | 08/20/2021 |
| 06/24/2021 | ALBIREO PHARMA, INC. | ALBO | Grant | Stock Option (right to buy) | 8k | $36.87 | $295k | | 06/24/2021 |
| 06/04/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 7.3k | $61.32 | $449.2k | | 06/04/2021 |
| 04/13/2021 | Liquidia Corp | | Purchase | Common Stock | 99.2k | $2.52 | $250k | | 04/13/2021 |
| 03/24/2021 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 30.4k | $2.51 | $76.2k | | 03/24/2021 |
| 03/05/2021 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 1.5k | $65.02 | $95.1k | | 03/05/2021 |
| 11/18/2020 | Liquidia Corp | | Other (acquisition) | Common Stock | 1.4M | $6.00 | $8.3M | See footnote | 11/18/2020 |
| 11/18/2020 | Liquidia Corp | | Grant | Non-Qualified Stock Option (right to buy) | 30k | $3.38 | $101.4k | | 11/18/2020 |
| 06/19/2020 | ALBIREO PHARMA, INC. | ALBO | Grant | Stock Option (right to buy) | 8k | $27.89 | $223.1k | | 06/19/2020 |
| 06/05/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 13k | $77.38 | $1M | | 06/05/2020 |
| 03/17/2020 | Axsome Therapeutics, Inc. | AXSM | Grant | Stock Option (Right to Buy) | 4.5k | $45.14 | $202.9k | | 03/17/2020 |
| 01/10/2020 | Axsome Therapeutics, Inc. | AXSM | Exercise | Stock Option (Right to Buy) | 34.9k | $12.95 | $451.5k | | 01/10/2020 |
| 01/10/2020 | Axsome Therapeutics, Inc. | AXSM | Exercise | Stock Option (Right to Buy) | 9.1k | $9.00 | $82.1k | | 01/10/2020 |
| 01/10/2020 | Axsome Therapeutics, Inc. | AXSM | Exercise | Stock Option (Right to Buy) | 5.2k | $8.02 | $41.6k | | 01/10/2020 |
| 01/10/2020 | Axsome Therapeutics, Inc. | AXSM | Exercise | Stock Option (Right to Buy) | 11k | $4.95 | $54.4k | | 01/10/2020 |
| 11/12/2019 | Dova Pharmaceuticals, Inc. | DOVA | Disposition | Common Stock | 67k | $0.00 | $0 | | 11/12/2019 |
| 11/12/2019 | Dova Pharmaceuticals, Inc. | DOVA | Disposition | Stock Option (Right to Buy) | 33k | $7.32 | $241.6k | | 11/12/2019 |
| 11/12/2019 | Dova Pharmaceuticals, Inc. | DOVA | Disposition | Stock Option (Right to Buy) | 10k | $9.36 | $93.6k | | 11/12/2019 |
| 07/03/2019 | Axsome Therapeutics, Inc. | AXSM | Exercise | Stock Option (Right to Buy) | 39.9k | $2.85 | $113.9k | | 07/03/2019 |
|